About
▼
Careers
Internship
MedBlog
Contact us
English (US)
▼
LOGIN
REGISTER
☰
Explore
Healthy Living
News
Health A-Z
Calculators
Articles
Drugs
Directories
Education
More
Latest Press Releases
Submit Press Releases
‹
›
Advertisement
Medindia
»
Health Press Releases A-Z
Biohaven Announces Exclusive License With Catalent For Zydis® Orally Dissolving Tablet With Small Molecule CGRP Receptor Antagonists
Wednesday, February 21, 2018
Medico Legal News
Advertisement
Latest Press Release on Medico Legal News
Dry Eye Foundation Applauds Breakthrough Investigation of OTC Eye Drop Safety Issues
Bloomberg Businessweek's "No Testing, No Inspections: Contaminated Eyedrops Blinded and Killed Americans" story exposes "gaping hole" in regulatory system POULSBO, Wash. , July 2...
Dry Eye Foundation Calls on Retailers to Address Rampant Sales of Potentially Unsafe Eye Drops
More than 50 "red flag" eye drops found on popular e-commerce marketplaces POULSBO, Wash. , May 4, 2023 /PRNewswire/ -- Dry Eye Foundation has identified more than 50 eye dr...
COVID-19 Continues to Haunt Area Nursing Homes: Wrongful Death Attorney Brian P. Murphy Sees Post-Pandemic Uptick in NJ and PA Bedsore Cases
The Law Firm of Brian P. Murphy, PC , is experiencing an increase in calls from nursing home residents' family members seeking to pursue nursing home malpractice and wrongful death acti...
EzriCare Eyedrops Lawsuit
, March 24, 2023 /PRNewswire/ -- EzriCare artificial tears are over-the-counter eyedrops used as a lubricant for eyes, relieving dry, irritated eyes. Carboxymethylcellulose sodium...
Suppressed Government Report Finding Fluoride Can Reduce Children's IQ Made Public Under EPA Lawsuit
NORTH SUTTON, N.H. , March 15, 2023 /PRNewswire/ -- The final report of a 6-year National Toxicology Program (NTP) review of fluoride neurotoxicity was blocked from public releas...
About Us
Editorial Team
Exclusive Interviews
In the News
Partners & Affiliates
Advertise With Us
Sitemap
हिन्दी
français
Español
中文
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our
Cookie Policy
,
Privacy Policy
, and our
Terms of Use
Ok, Got it.
Close
↑